Alamar Biosciences Raises $128 Million in Oversubscribed Series C Financing to Accelerate Commercialization of its Proteomics Platform
Amount Raised
$128 Million
Round Type
Series C
FremontBiotechnologyInvestors
Description
Alamar Biosciences raised $128 million in an oversubscribed Series C financing led by Sands Capital, bringing the total capital raised to nearly $250 million. The financing included participation from new financial and strategic investors as well as existing major investors. The first close of $100 million was announced with the second close of an additional $28 million expected to happen within the next 30 days. The company plans to use the funds to grow the commercial and customer support teams, drive market adoption, and expand the product menu.
Quick answer
Alamar Biosciences raised $128 Million in a Series C round, dated February 26, 2024. Investors: Sands Capital. Alamar Biosciences is based in Fremont, California, United States.
- How much did Alamar Biosciences raise?
- Alamar Biosciences raised $128 Million in a Series C round on February 26, 2024.
- Who invested in Alamar Biosciences?
- Sands Capital is named as investors in this round.
- What does Alamar Biosciences do?
- Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease.
- Where is Alamar Biosciences based and how big is it?
- Alamar Biosciences is based in Fremont, California, United States. Fundz records about 173 employees.
- Who are the decision-makers at Alamar Biosciences?
- Fundz holds 1 contact at Alamar Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Alamar Biosciences that raised within 45 days of this round, from Fundz verified event records.
- RenovoRx raised $11M on April 11, 2024.
- Qlaris Bio raised $24M on April 11, 2024.
- Enatom raised $967K (Seed) on April 11, 2024.
- DeepCure raised $25M (Series A) on April 11, 2024.
- FundaMental Pharma raised $14M (Seed) on April 11, 2024.
- Insight Molecular Diagnostics Inc. raised $16M on April 11, 2024.
Who to call at Alamar Biosciences, and when
A new round usually means Alamar Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alamar Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alamar Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alamar Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alamar Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alamar Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.